2010 Scrip 100 - Rich pickings for biosimilars?
09 December 2009
Ian Schofield
While the US, Europe and Japan each get to grips with the challenges posed by off-patent biologics, the debate has now turned to the global stage. Ian Schofield reports.
Europe may have blazed the biosimilars trail by implementing a dedicated approval pathway, but it had...
Please Login to read the full article.